ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

FCGR3A: A new biomarker with potential prognostic value for prostate cancer

Zha, Zeyu; Hong, Yuan; Tang, ZhenFeng; Du, Qiuling; Wang, Yan; Yang, Shengbang; Wu, Yongding; Tan, Huijing; Jiang, Funneng; Zhong, Weide*广州中医药大学; 贵州大学; 1
Frontiers in Oncology2022-11-24DOI: 10.3389/fonc.2022.1014888
1被引8阅读
引用收藏
分享

摘要

To screen target gene cluster by bioinformatics analysis and verify them by in vitro experiment and clinicopathological correlation analysis. We try to find a new biomarker with prognostic value for prostate cancer (PCa). 42 candidate marker genes were constructed by protein protein interaction (PPI) network and enriched by KEGG pathway to find out the gene cluster we are interested in. Prognostic model was established to preliminarily analyze the prognostic value of this gene cluster in PCa, and Cox risk regression was used for comparative analysis. Immunohistochemistry was used to detect the expression of each gene in clinical tissue microarray. Finally, we analyzed the correlation between each gene and their clinicopathological features of PCa combined with TCGA clinical data. Based on the analysis of PPI and KEGG, we found the target gene cluster (FCGR3A, HAVCR2, CCR7 and CD28). Prognostic model analysis showed that this gene cluster had the ability to predict biochemical recurrence, and the survival rate and ROC analysis showed favorable prediction effect. Univariate Cox regression analysis showed that the risk scores of Gleason score (GS), T stage, N stage and PSA were significantly different (P<0.05), and the risk ratio of high expression was 2.30 times that of low expression (P=0.004). However, it was not statistically significant in multivariate Cox regression analysis (P>0.05). The results of tissue microarray showed that FCGR3A and HAVCR2 were highly expressed in PCa (P<0.01), while the expression of CCR7 and CD28 had no significant difference (P>0.05). Kaplan-Meier analysis showed that there was significant difference in BCR free survival of FCGR3A and HAVCR2 (FCGR3A, P=0.010; HAVCR2, P=0.018), while the expression of CCR7 and CD28 had no significant difference on the survival and prognosis of PCa patients (P>0.05). TCGA clinical data analysis found that the expression of FCGR3A had a unique correlation with the clinicopathological features of PCa, which was closely related to the tumor stage. The expression of FCGR3A is related to BCR free survival of PCa patients. Therefore, FCGR3A is a new biomarker with potential prognostic value of PCa.

学科与关键词

关键词
prostate cancerprognosisFCGR3Atumor microenvironmentbioinformatics analysis
相关
加载中…
  • Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer
    Wang, Wenxuan; Wu, Qinghui; Mohyeddin, Ali; Liu, Yousheng; Liu, Zhitao; Ge, Jianqiang; Zhang, Bao; Shi, Gan; Wang, Weifu*; Wu, Dinglan*; Wang, Fei*Computational and Mathematical Methods in Medicine, 2022, 2022: 5500416.
  • Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker
    Wang, Lei*; Liu, Xudong; Liu, Zhe; Wang, Yafan; Fan, Mengdi; Yin, Jinyue; Zhang, Yu; Ma, Ying; Luo, Jia; Li, Rui; Zhao, Xue; Zhang, Peiju; Zhao, Lijun; Fan, Jinke; Chen, Yuxuan; Lu, Wei*; Song, Xinqiang*Scientific Reports, 2022, 12(1): 192.被引 7
  • Immune-related biomarker risk score predicts prognosis in prostate cancer
    Liu, Zezhen; Zhong, Jiehui; Cai, Chao; Lu, Jianming; Wu, Wenqi; Zeng, Guohua*Aging-US, 2020, 12(22): 22776-22793.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-11-24
卷期
第 12 卷
页码
1014888
DOI
10.3389/fonc.2022.1014888
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Scientific research start-up project of Guangzhou First People's Hospital; Guangzhou General Science and Technology Project of Health and Family Planning; Guangzhou Planned Project of Science and Technology; [82072813]; [81571427]; [KYQD0004]; [20201A011012]; [202102010038]; [202102080029]

作者

  • Z

    Zha, Zeyu (第一作者)

    2 · bengbu med coll · 1

  • H

    Hong, Yuan

    1 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • T

    Tang, ZhenFeng

    1

  • D

    Du, Qiuling

    1

  • W

    Wang, Yan

    1

  • Y

    Yang, Shengbang

    guizhou univ · 1

  • W

    Wu, Yongding

    1

  • T

    Tan, Huijing

    1

  • J

    Jiang, Funneng

    1

  • Z

    Zhong, Weide (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417